Heat Biologics Inc (HTBX) is higher by Wednesday morning, with the stock adding 4.64% in pre-market trading to 7.22.
HTBX's short-term technical score of 29 indicates that the stock has traded less bullishly over the last month than 71% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, Heat Biologics Inc ranks higher than 40% of stocks.
Heat Biologics Inc has risen 20.21% over the past month, closing at $5.74 on December 23. During this period of time, the stock fell as low as $5.28 and as high as $7.37. HTBX has an average analyst recommendation of Strong Buy. The company has an average price target of $28.62.
Heat Biologics Inc has a Long-Term Technical rank of 24. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 76% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, HTBX ranks better than 41% of stocks.
Important Dates for Investors in HTBX:
-Heat Biologics Inc is set to release earnings on 2/8/2021. During their last earnings release the company posted EPS of $-2.24. -We do not have a set dividend date for Heat Biologics Inc at this time. Click Here to get the full Stock Score Report on Heat Biologics Inc (HTBX) Stock.
